1826 Organometallics, Vol. 21, No. 9, 2002
Evans et al.
mide (HMPA) were purchased from Aldrich, dried over acti-
vated 3A molecular sieves, and degassed with three freeze-
pump-thaw cycles before use. ꢀ-Caprolactam was purchased
from Aldrich and sublimed before use. Benzophenone was
purchased from Fisher and used as received. (C5Me5)2YCl(µ-
Cl)Y(C5Me5)2 (1) was prepared as previously described.9 (C5-
Me5)2YCl(THF)1 was synthesized by a modified procedure as
described below. 1H and 13C NMR spectra were obtained on
an Omega 500 MHz or a GN 500 MHz spectrometer at 25 °C.
X-ray crystallographic data were obtained on a Bruker CCD
platform diffractometer. IR spectra were taken on thin films
obtained from benzene solutions (except where noted) using
an ASI ReactIR 1000 spectrometer. Complexometeric analyses
were obtained as previously described.11
(C6D6): 181.9 (CO), 117.0 (C5Me5), 42.5 (CH2), 36.4 (CH2), 30.0
(CH2), 28.3 (CH2), 22.6 (CH2), 11.4 (C5Me5). IR: 3205 m, 2927
s, 2858 s, 1630 vs, 1498 m, 1437 s, 1359 m, 1259 m, 1205 m,
1089 s, 1020 s, 803 s cm-1
.
(C5Me5)2YCl(1-m eth yl-2-p yr r olid in on e) (8). A white solid
(47.6 mg, 96%) was obtained from 1-methyl-2-pyrrolidinone
(10 mg, 0.10 mmol) and 1 (40 mg, 0.05 mmol). Anal. Calcd for
C25H39ClNOY: Y, 18.0. Found: Y, 17.5. 1H NMR (C6D6): δ 2.25
(s, 3H), 2.11 (s, 30H), 1.64 (m, 2H), 1.42 (m, 2H), 0.98 (m, 2H).
13C NMR (C6D6): δ 176.6 (CO), 116.6 (C5Me5), 49.9 (CH2), 31.5
(CH2), 30.2 (CH2), 17.4 (CH3), 1164 (C5Me5). IR: 2904 s, 1645
vs, 1514 m, 1444 m, 1313 m, 1259 m, 1112 m, 1027 m, 803 w,
765 w cm-1
.
(C5Me5)2YCl(DMP U) (9). A white solid (54 mg, 90%) was
isolated from DMPU (15 mg, 0.12 mmol) and 1 (45 mg, 0.056
mmol). Anal. Calcd for C26H42ClN2OY: Y, 17.0. Found: Y, 16.8.
1H NMR (C6D6): δ 2.82 (s, 3H), 2.45 (s, 3H), 2.22 (m, 2H), 2.18
(m, 2H), 2.15 (s, 30H), 0.91 (m, 2H). 13C NMR (C6D6): δ 157.3
(CO), 116.7 (C5Me5), 47.6 (CH2), 47.0 (CH2), 38.3 (CH3), 36.6
(CH3), 20.6 (CH2), 11.8 (C5Me5). IR: 2920 s, 2858 s, 1576 vs,
Typ ica l P r oced u r e for th e Syn th esis of (C5Me5)2YCl-
(L). P r ep a r a tion of (C5Me5)2YCl(THF ) (2). In a glovebox,
THF (14 mg, 0.20 mmol) in 5 mL of benzene was added to a
slurry of 1 (30 mg, 0.038 mmol) in about 1 mL of benzene.
The slurry instantly became a colorless solution. After 1 h of
stirring, the solvent was removed by rotary evaporation and
the white solid, 2, was obtained (35 mg, 80%) and identified
1413 w, 1321 w, 1259 s, 1020 vs, 905 w, 865 w, 766 vs cm-1
.
1
by H NMR spectroscopy.1
(C5Me5)2YCl(E-ca p r ola cta m )2 (10). The reaction of excess
ꢀ-caprolactam (60 mg, 0.53 mmol) with 1 (70 mg, 0.089 mmol)
gave a white solid which crystallized with one caprolactam in
the lattice, (C5Me5)2YCl(ꢀ-caprolactam)2‚(caprolactam) (125 mg,
96%). Anal. Calcd for C38H63ClN3O3Y: Y, 12.1. Found: Y, 12.3.
1H NMR (C6D6): δ 8.17 (b, 3H, ∆ν1/2 ) 49 Hz), 2.50 (m, 6H),
2.14 (m, 6H), 2.11 (s, 30H), 1.30 (m, 6H), 1.15 (m, 6H), 1.03
(m, 6H). 13C NMR (C6D6): δ 179.5 (CO), 116.5 (C5Me5), 42.4
(CH2), 36.8 (CH2), 30.4 (CH2), 29.5 (CH2), 23.2 (CH2), 11.7
(C5Me5). IR: 3290 w, 3205 m, 3051 w, 2927 s, 2858 s, 1637 vs,
1483 m, 1437 m, 1359 m, 1197 m, 1120 m, 1020 m, 981 w, 811
(C5Me5)2YCl(L) (L ) Ben zop h en on e (3), MMA (4), E-Ca -
p r ola cton e (5), HMP A (6), E-Ca p r ola cta m (7), 1-Meth yl-
2-p yr r olid in on e (8), DMP U (9)). 3-9 were prepared as
described for 2. Reagents, yields, and spectroscopic data for
individual samples are given below.
(C5Me5)2YCl(ben zop h en on e) (3). A dark red solid (40 mg,
91%) was isolated from benzophenone (14 mg, 0.08 mmol) and
1 (30 mg, 0.038 mmol). Anal. Calcd for C33H40ClOY: Y, 15.4.
Found: Y, 15.1. 1H NMR (C6D6): δ 7.76 (b, 4H, ∆ν1/2 ) 100
Hz), 7.10 (m, 2H), 7.04 (m, 4H), 2.04 (s, 30H). 13C NMR
(C6D6): δ 206.6 (CO), 135.1 (o-C), 132.3 (m-C), 129.3 (p-C),
117.8 (C5Me5), 11.8 (C5Me5). IR: 3059 w, 2912 s, 2858 s, 1614
s, 1568 s, 1444 s, 1328 s, 1290 s, 1159 m, 1081 s, 1027 s, 942
m, 803 m, 703 s cm-1. UV-vis (hexanes; λmax, nm (ꢀ, M-1cm-1)):
457 (1460).
m cm-1
.
X-r a y Da ta Collection , Str u ctu r e Deter m in a tion , a n d
Refin em en t. (C5Me5)2YCl(ben zop h en on e) (3). Complexes
3-10 were handled as described in detail here for 3, except
for the specific comments which follow. A red crystal of
approximate dimensions 0.15 × 0.28 × 0.49 mm was mounted
on a glass fiber and transferred to a Bruker CCD platform
diffractometer. The SMART12 program package was used to
determine the unit-cell parameters and for data collection (20
s/frame scan time for a sphere of diffraction data). The raw
frame data were processed using SAINT13 and SADABS14 to
yield the reflection data file. Subsequent calculations were
carried out using the SHELXTL15 program. The diffraction
symmetry was 2/m, and the systematic absences were consis-
tent with the centrosymmetric monoclinic space group P21/c,
which was later determined to be correct. Details are given in
Table 1.
The structure was solved by direct methods and refined on
F2 by full-matrix least-squares techniques. Analytical scatter-
ing factors16 for neutral atoms were used throughout the
analysis. Hydrogen atoms were included using a riding model.
(C5Me5)2YCl(E-ca p r ola cton e) (5). The pentamethylcyclo-
pentadienyl and caprolactone ligands exhibited a high degree
of thermal motion. The ring defined by C(11)-C(15) was
refined with isotropic thermal parameters using multiple
components with partial site-occupancy factors (0.60/0.40
major/minor components). The disordered atoms of the capro-
lactone ligand were also handled in this manner. It was
necessary to include bond distance constraints for this ligand.
(C5Me5)2YCl(MMA) (4). A yellow solid was isolated (50 mg,
94%) from MMA (10 mg, 0.10 mmol) and 1 (43 mg, 0.054
mmol). Anal. Calcd for C25H38ClO2Y: Y, 18.0. Found: Y, 18.2.
1H NMR (C6D6): δ 6.19 (m, 1H), 5.20 (m, 2H), 3.56 (s, 3H),
2.02 (s, 30H), 1.56 (s, 3H). 13C NMR (C6D6): δ 175.5 (CO),-
134.7 (CCdC), 131.8 (CH2), 117.6 (C5Me5), 56.8 (OCH3), 17.8
(CH3), 11.7 (C5Me5). IR: 2920 vs, 2858 vs, 1661 s, 1630 s, 1560
m, 1444 s, 1375 m, 1328 s, 1259 s, 1089 s, 1020 vs, 803 vs
cm-1
.
(C5Me5)2YCl(E-Ca p r ola cton e) (5). A white solid (49 mg,
94%) was obtained from the reaction between 1 (40 mg, 0.051
mmol) and ꢀ-caprolactone (12 mg, 0.11 mmol). Anal. Calcd for
C
26H40ClO2Y: Y, 17.5. Found: Y, 17.9. 1H NMR (C6D6): δ 3.35
(m, 2H), 2.40 (m, 2H), 2.09 (s, 30H), 1.22 (m, 2H), 0.95 (m,
4H). 13C NMR (C6D6): δ 185.7 (CO), 117.2 (C5Me5), 33.4 (CH2),
31.9 (CH2), 28.2 (CH2), 28.1 (CH2), 22.7 (CH2), 11.5 (C5Me5).
IR: 2904 s, 2866 s, 1688 vs, 1437 m, 1359 m, 1305 m, 1259 m,
1189 m, 1097 m, 1043 m, 803 w, 703 w cm-1
.
(C5Me5)2YCl(HMP A) (6). A white solid (68 mg, 93%) was
obtained from HMPA (23 mg, 0.12 mmol) and 1 (50 mg, 0.063
mmol). Anal. Calcd for C26H66ClN3OPY: Y, 15.0. Found: Y,
15.3. 1H NMR (C6D6): δ 2.18 (s, 30H), 2.18 (d, 18H, J ) 10
Hz). 13C NMR (C6D6): δ 117.0 (C5Me5), 37.4 (CH2, J C-P ) 20
Hz), 12.0 (C5Me5). IR: 2920 s, 2858 s, 1591 w, 1444 m, 1305 s,
1189 s, 1128 vs, 989 vs, 757 w cm-1
.
(C5Me5)2YCl(E-ca p r ola cta m ) (7). A white solid (68 mg,
94%) was isolated from ꢀ-caprolactam (16 mg, 0.14 mmol) and
1 (56 mg, 0.071 mmol) in 15 mL of benzene. Anal. Calcd for
C26H41ClNOY: Y, 17.5. Found: Y, 18.0. 1H NMR (C6D6): δ 8.67
(br, 1H, ∆ν1/2 ) 28 Hz), 2.30 (m, 2H), 2.08 (s, 30H), 1.90 (m,
2H), 1.17 (m, 2H), 1.08 (m, 2H), 0.88 (m, 2H). 13C NMR
(12) SMART Software Users Guide, Version 5.1; Bruker Analytical
X-ray Systems, Inc., Madison, WI, 1999.
(13) SAINT Software Users Guide, Version 6.0; Bruker Analytical
X-ray Systems, Inc., Madison, WI, 1999.
(14) Sheldrick, G. M. SADABS; Bruker Analytical X-ray Systems,
Inc.; Madison, WI, 1999.
(15) Sheldrick, G. M. SHELXTL Version 5.10; Bruker Analytical
X-ray Systems, Inc.; Madison, WI, 1999.
(11) Taylor, M. D.; Carter, C. D. J . Inorg. Nucl. Chem. 1962, 24,
387-391.
(16) International Tables for X-ray Crystallography; Kluwer Aca-
demic: Dordrecht, The Netherlands, 1992; Vol. C.